Vibegron Patent Expiration
Vibegron is Used for treating overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. It was first introduced by Urovant Sciences Gmbh
Vibegron Patents
Given below is the list of patents protecting Vibegron, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Gemtesa | US8247415 | Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists | Dec 01, 2030 | Urovant |
| Gemtesa | US8653260 | Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists | Apr 02, 2029 | Urovant |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳